Skip to main content

Fluoroquinolones-resistant Shigella species in Iranian children: a meta-analysis

Abstract

Background

Shigella is one of the most common causes of childhood dysentery along with high rate of morbidity and mortality in both developing and developed countries. According to the World Health Organization (WHO) reports, the prevalence of fluoroquinolones-resistant Shigella species is increasing worldwide which can cause treatment failure of Shigella infections. Since there has not been any comprehensive information on drug-resistant Shigella species in Iran, we conducted the following meta-analysis to raise awareness.

Methods

We conducted a literature search on antibiotic resistance of Shigella species to collect published studies in Iran using national and international databases. Literature search was performed by up to Jan 30, 2019 and eligible studies were included in the meta-analysis by predefined criteria.

Results

Antimicrobial susceptibility testing using disk diffusion technique was the only used method in all included studies. Antibiotic resistance characteristics of Shigella species against WHO recommended therapeutic regimens were as follows: S. dysenteriae 7%, S. flexneri 3.8%, S. boydii 6.9% and S. sonnei 2.6% to ciprofloxacin, S. dysenteriae 27.9%, S. flexneri 19.3%, S. boydii 15.7% and S. sonnei 9.5% to ceftriaxone and also S. dysenteriae 91.7%, S. flexneri 20.7%, S. boydii 46.7% and S. sonnei 32.3% to azithromycin. Resistance to pivmecillinam has not been investigated in Iran.

Conclusions

Our findings revealed that ciprofloxacin can still be used as the first-line antibiotic for Shigella infections in Iranian children. However, it seems that second-line antibiotics i.e., ceftriaxone and azithromycin are not good choices for treatment and thus not recommended.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology. 8th ed. London: Elsevier Health Sciences; 2015. p. 260–1.

    Google Scholar 

  2. Killackey SA, Sorbara MT, Girardin SE. Cellular aspects of Shigella pathogenesis: focus on the manipulation of host cell processes. Front Cell Infect Microbiol. 2016;6:38.

    Article  Google Scholar 

  3. WHO. The treatment of diarrhoea: a manual for physicians and other senior health workers. Geneva: World Health Organization; 2005.

    Google Scholar 

  4. Tickell KD, Brander RL, Atlas HE, Pernica JM, Walson JL, Pavlinac PB. Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1235–48.

    Article  Google Scholar 

  5. GBD Diarrhoeal Diseases Collaborators. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17:909–48.

    Article  Google Scholar 

  6. WHO. WHO publishes list of bacteria for which new antibiotics are urgently needed. Geneva: WHO; 2017.

    Google Scholar 

  7. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.

    Article  Google Scholar 

  8. Jomezadeh N, Babamoradi S, Kalantar E, Javaherizadeh H. Isolation and antibiotic susceptibility of Shigella species from stool samples among hospitalized children in Abadan, Iran. Gastroenterol Hepatol Bed Bench. 2014;7:218–23.

    PubMed  PubMed Central  Google Scholar 

  9. Nikfar R, Shamsizadeh A, Darbor M, Khaghani S, Moghaddam M. A Study of prevalence of Shigella species and antimicrobial resistance patterns in pediatric medical center, Ahvaz, Iran. Iran J Microbiol. 2017;9:277–83.

    PubMed  PubMed Central  Google Scholar 

  10. Barak M, Arzanlou M, Babapour B, Ghorbani L. Antibiotic resistance pattern of bacterial enteritis among hospitalized children in Ardabil: a single center experience. Int J Adv Med. 2016;3:989–93.

    Article  Google Scholar 

  11. Ebrahimi AA, Ebrahimi S, Aghouli M. Survey of resistance rate of Shigella species isolated from children with diarrhea in Fasa, Summer, 1383. Iran South Med J. 2009;12:225–30 (in Persian).

    Google Scholar 

  12. Mashouf RY, Moshtaghi AA, Hashemi SH. Epidemiology of Shigella species isolated from diarrheal children and drawing their antibiotic resistance pattern. Iran J Clin Infect Dis. 2006;1:149–55.

    Google Scholar 

  13. Masiha AR, Khoshkholgh Pahlaviani MRM, Isazadeh K. The assessment of antimicrobial susceptibility patterns of clinical isolates of Shigella spp. from diarrheal specimens of children in Iran. J Biol Sci. 2011;4:83–92 (in Persian).

    Google Scholar 

  14. Farshad S, Sheikhi R, Japoni A, Basiri E, Alborzi A. Characterization of Shigella strains in Iran by plasmid profile analysis and PCR amplification of ipa genes. J Clin Microbiol. 2006;44:2879–83.

    CAS  Article  Google Scholar 

  15. Talebreza A, Memariani M, Memariani H, Shirazi MH, Shamsabad PE, Bakhtiari M. Prevalence and antibiotic susceptibility of Shigella species isolated from pediatric patients in Tehran. Arch Pediatr Infect Dis. 2016;4:e32395.

    Google Scholar 

  16. Rostamzad A. Molecular epidemiology of Shigella sonnei isolated from clinical cases in Tehran using RAPD-PCR method. Glob Adv Res J Med Med Sci. 2015;4:207–12.

    Google Scholar 

  17. Pourakbari B, Mamishi S, Mashoori N, Mahboobi N, Ashtiani MH, Afsharpaiman S, et al. Frequency and antimicrobial susceptibility of Shigella species isolated in Children Medical Center Hospital, Tehran, Iran, 2001–2006. Braz J Infect Dis. 2010;14:153–7.

    Article  Google Scholar 

  18. Jafari F, Hamidian M, Salmanzadeh-Ahrabi S, Bolfion M, Kharaziha P, Yaghobi M, et al. Molecular diagnosis and antimicrobial resistance pattern of Shigella spp. isolated from patients with acute diarrhea in Tehran, Iran. Gastroenterol Hepatol Bed Bench. 2008;1:11–7.

    Google Scholar 

  19. Sakhaei A, Savari M, Shokoohizadeh L, Hadian M, Ekram A. Characterization of Shigella strains by plasmid profile analysis and antibiotic susceptibility patterns in a pediatric hospital in Ahvaz. Int J Enteric Pathog. 2015;3:1–6.

    Article  Google Scholar 

  20. Khaghani S, Shamsizadeh A, Nikfar R, Hesami A. Shigella flexneri: a three-year antimicrobial resistance monitoring of isolates in a Children Hospital, Ahvaz, Iran. Iran J Microbiol. 2014;6:225–9.

    PubMed  PubMed Central  Google Scholar 

  21. Aminshahidi M, Arastehfar A, Pouladfar G, Arman E, Fani F. Diarrheagenic Escherichia coli and Shigella with high rate of extended-spectrum beta-lactamase production: two predominant etiological agents of acute diarrhea in Shiraz, Iran. Microb Drug Resist. 2017;23:1037–44.

    CAS  Article  Google Scholar 

  22. Soltan Dallal MM, Omidi S, Douraghi M, Ashtiani MT, Yazdi MK, Okazi A. Molecular analysis of integrons and antimicrobial resistance profile in Shigella spp. isolated from acute pediatric diarrhea patients. GMS Hyg Infect Control. 2018;13:Doc02.

    PubMed  PubMed Central  Google Scholar 

  23. Mahmoudi S, Pourakbari B, Moradzadeh M, Eshaghi H, Ramezani A, Ashtiani MT, et al. Prevalence and antimicrobial susceptibility of Salmonella and Shigella spp. among children with gastroenteritis in an Iranian referral hospital. Microb Pathog. 2017;109:45–8.

    Article  Google Scholar 

  24. Farahani NN, Jazi FM, Nikmanesh B, Asadolahi P, Kalani BS, Amirmozafari N. Prevalence and antibiotic susceptibility patterns of Salmonella and Shigella species isolated from pediatric diarrhea in Tehran. Arch Pediatr Infect Dis. 2018;6:e57328.

    Google Scholar 

  25. Noroozi J, Kazemi B, Hakemi Vala M. Study of isolation and determination of antibiotic resistance, plasmid profiles, protein bands and phenotypic virulence of Shigella flexneri strains. SJKU. 2007;11:63–73 (in Persian).

    Google Scholar 

  26. Hajizade N, Daneshjo K. Evaluation of in vitro antimicrobial drug-resistance in Imam Khomini hospital. Iran J Pediatr. 2003;13:133–40 (in Persian).

    Google Scholar 

  27. Ranjbar R, Mammina C, Pourshafie MR, Soltan-Dallal MM. Characterization of endemic Shigella boydii strains isolated in Iran by serotyping, antimicrobial resistance, plasmid profile, ribotyping and pulsed-field gel electrophoresis. BMC Res Notes. 2008;1:74.

    Article  Google Scholar 

  28. Dolatshahi Z, Amini K. Survey of tetracycline resistance genes in Shigella sonnei isolated from acute pediatric with bacterial diarrhea using multiplex PCR method and their antibiotic resistance patterns. Zanko J Med Sci. 2016;17:35–44 (in Persian).

    Google Scholar 

  29. Soltan Dallal MM, Eghbal M, Sharafianpour A, Zolfaghari MR, Yazdi MK. Prevalence and multiple drug resistance of Shigella sonnei isolated from diarrheal stool of children. J Med Bacteriol. 2015;4:33.

    Google Scholar 

  30. Soltan Dallal MM, Nikmanesh B, Haghi-Ashtiani MT, Okazi A, Sharifi Yazdi MK. Serotyping and multiple antibiotic resistance patterns of Shigella Sonnei isolated from diarrhea in Children’s Medical Center of Tehran. J Payavard Salamat. 2018;11:560–6 (in Persian).

    Google Scholar 

  31. Afshari N, Bakhshi B, Mahmoudi-Aznaveh A, Fallah F, Rahbar M, Rafiei Tabatabaei SR. Investigation of prevalence of Shigella sonnei in children with diarrhea admitted to two hospital Emam Khomeini and Milad in Tehran in 1391 with antimicrobial susceptibility of isolates. Iran J Med Microbiol. 2016;10:16–22.

    Google Scholar 

  32. Ranjbar R, Soltan Dallal MM, Talebi M, Pourshafie MR. Increased isolation and characterization of Shigella sonnei obtained from hospitalized children in Tehran, Iran. J Health Popul Nutr. 2008;26:426–30.

    PubMed  PubMed Central  Google Scholar 

  33. Traa BS, Walker CL, Munos M, Black RE. Antibiotics for the treatment of dysentery in children. Int J Epidemiol. 2010;39(Suppl 1):i70–4.

    Article  Google Scholar 

  34. Gu B, Zhou M, Ke X, Pan S, Cao Y, Huang Y, et al. Comparison of resistance to third-generation cephalosporins in Shigella between Europe–America and Asia–Africa from 1998 to 2012. Epidemiol Infect. 2015;143:2687–99.

    CAS  Article  Google Scholar 

  35. Kahsay AG, Muthupandian S. A review on Sero diversity and antimicrobial resistance patterns of Shigella species in Africa, Asia and South America, 2001–2014. BMC Res Notes. 2016;9:422.

    Article  Google Scholar 

  36. Gu B, Cao Y, Pan S, Zhuang L, Yu R, Peng Z, et al. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe–America and Asia–Africa from 1998 to 2009. Int J Antimicrob Agents. 2012;40:9–17.

    CAS  Article  Google Scholar 

  37. Darton TC, Tuyen HT, The HC, Newton PN, Dance DAB, Phetsouvanh R, et al. Azithromycin resistance in Shigella spp. in Southeast Asia. Antimicrob Agents Chemother. 2018;62:e01748.

    CAS  Article  Google Scholar 

  38. Gu B, Ke X, Pan S, Cao Y, Zhuang L, Yu R, et al. Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999–2010. J Biomed Res. 2013;27:103–15.

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

No external funding was secured to conduct this study.

Author information

Affiliations

Authors

Contributions

FK presented idea, performed systematic search, data collection and meta-analysis; AS contributed to perform systematic search, to the analysis of the results and to the writing of the manuscript. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Farzad Khademi.

Ethics declarations

Ethical approval

Not needed.

Conflict of interest

The authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PPTX 34 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Khademi, F., Sahebkar, A. Fluoroquinolones-resistant Shigella species in Iranian children: a meta-analysis. World J Pediatr 15, 441–453 (2019). https://doi.org/10.1007/s12519-019-00263-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-019-00263-1

Keywords

  • Antibiotic resistance
  • Fluoroquinolone
  • Iran
  • Shigella